lunes, 28 de enero de 2019

Real-World Evidence Role in Regulatory and Payment Decision-making | Bipartisan Policy Center

Real-World Evidence Role in Regulatory and Payment Decision-making | Bipartisan Policy Center

Morning Rounds

Megan Thielking

FDA commissioners talk real-world evidence

FDA Commissioner Scott Gottlieb and three former FDA commissioners are teaming up today to talk about a hot topic in health care: real-world evidence. The amount of patient data that’s available to analyze — whether it’s pulled from electronic health records or gathered by patients themselves with apps and devices — is growing rapidly. That data could be valuable when it comes to figuring out not only how well a treatment works, but also how much it’s worth in value-based payment programs. At a Bipartisan Policy Center event this afternoon, Gottlieb and former FDA Commissioners Robert Califf, Mark McClellan, and Andrew von Eschenbach will explore new ways that real-world evidence can be used. 

The Role of Real-World Evidence in Regulatory and Value-Based Payment Decision-making

WHEN: Monday, January 28, 2019 3:00 p.m. to 5:00 p.m. ET
WHERE: Bipartisan Policy Center, 1225 Eye St NW, Suite 1000, Washington, DC, 20005
➤ REGISTER NOW

No hay comentarios: